Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically.
Subscribe Today
Breakthrough Devices would no longer enjoy a fast track to Medicare inpatient new technology add-on payments (NTAPs) and outpatient pass-through payments under a proposal from CMS. If finalized, the change would likely lead to a massive drop of new awards from the bonus payment programs that have grown in recent years.
Breakthrough Devices would no longer enjoy a fast track to Medicare inpatient new technology add-on payments (NTAPs) and outpatient pass-through payments under a proposal from CMS. If finalized, the change would likely lead to a massive drop of new awards from the bonus payment programs that have grown in recent years.
Breakthrough Devices would no longer enjoy a fast track to Medicare inpatient new technology add-on payments (NTAPs) and outpatient pass-through payments under a proposal from CMS. If finalized, the change would likely lead to a massive drop of new awards from the bonus payment programs that have grown in recent years.